| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/14/2005 | EP1572888A2 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 09/14/2005 | EP1572883A2 Human cytokine receptor |
| 09/14/2005 | EP1572881A2 Tacis and br3 polypeptides and uses thereof |
| 09/14/2005 | EP1572871A2 T1r3 a novel taste receptor |
| 09/14/2005 | EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 09/14/2005 | EP1572862A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 09/14/2005 | EP1572740A2 Targeting single epitopes |
| 09/14/2005 | EP1572149A2 Immunogenicity of glucan binding protein |
| 09/14/2005 | EP1572116A2 Compositions and methods for the treatment of immune related diseases |
| 09/14/2005 | EP0833933B1 A vector and method for producing influenza hemagglutinin |
| 09/14/2005 | CN1668721A Immunoadhesin comprising a glycoprotein VI domain |
| 09/14/2005 | CN1668630A Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/14/2005 | CN1666997A Fusion protein, gene encoding same, and use thereof |
| 09/14/2005 | CN1666996A Fusion protein, gene encoding same, and expression method and use thereof |
| 09/13/2005 | US6943240 Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist |
| 09/13/2005 | US6943239 Antigenic fusionprotein carrying Galα1,3Gal epitopes |
| 09/13/2005 | US6942853 Latent fusion protein |
| 09/09/2005 | WO2005082941A1 Bone sialoprotein collagen-binding peptides |
| 09/09/2005 | WO2005082933A1 Novel chimeric protein, gene encoding the same, and means of judging leukemia using the gene and the protein |
| 09/09/2005 | WO2005014623A3 Compounds comprising lpa |
| 09/09/2005 | WO2004111090A3 Molecules for targeting and releasing therapeutic compounds, and the use thereof |
| 09/09/2005 | CA2841741A1 Monomethylvaline compounds capable of conjugation to ligands |
| 09/09/2005 | CA2575416A1 Bone sialoprotein collagen-binding peptides |
| 09/09/2005 | CA2552351A1 Method for determination and quantification of radiation or genotoxin exposure |
| 09/08/2005 | US20050197295 Modified annexin proteins and methods for preventing thrombosis |
| 09/07/2005 | EP1570058A1 Regulatory zinc finger proteins |
| 09/07/2005 | EP0842282B1 Alfa-beta c4bp-type recombinant heteromultimeric proteins |
| 09/07/2005 | CN1665934A GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1, 4)-N-acetylglucosaminyltransferase III) expression in plants |
| 09/07/2005 | CN1665931A Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 09/07/2005 | CN1665543A Fusions of cytokines and tumor targeting proteins |
| 09/07/2005 | CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665530A Immunogenic composition |
| 09/07/2005 | CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1663963A Hybrid interferon compositions and methods of use |
| 09/06/2005 | US6939959 Efficient protein expression system |
| 09/06/2005 | US6939853 Administering glucagon-like peptide 1 (GLP-1) compound and an effective amount of an antidyslipidemic drug for therapy of dyslipidemia |
| 09/06/2005 | US6939697 Isolating and purifying therapeutic polypeptide using undulating solid support comprising polyethersulphone |
| 09/01/2005 | WO2005080586A1 Fusion proteins containing recombinant cytotoxic rnases |
| 09/01/2005 | WO2005080418A2 Multimerised hiv fusion inhibitors |
| 09/01/2005 | WO2005066203A3 Targeted immunogens |
| 09/01/2005 | WO2005051997A3 Fusion proteins and detergent compositions comprising them |
| 09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 09/01/2005 | US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 09/01/2005 | CA2555661A1 Fusion proteins containing recombinant cytotoxic rnases |
| 08/31/2005 | EP1568376A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 08/31/2005 | EP1567641A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 08/31/2005 | EP1567550A2 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 08/31/2005 | EP1395612B1 Modified recombinase |
| 08/31/2005 | EP1173475B1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 08/31/2005 | CN1662555A Chimeric antagonist ANTH1 |
| 08/31/2005 | CN1660913A Immunoassays for anti-HCV antibodies |
| 08/31/2005 | CN1216902C Specific protein of SARS virus, clinical detection method and kit |
| 08/31/2005 | CN1216901C Method for cleaving chimeric protein using processing enzyme |
| 08/30/2005 | US6936475 Hybrid green fluorescent protein (GFP) which binds, measures and detects calcium using fluorescent/chemiluminescence resonance energy transfer (F/CRET) |
| 08/30/2005 | US6936439 Given DNA sequence; Fc immunoglobulin region attached; transforming cell; use in treating obesity |
| 08/30/2005 | US6936425 Attenuated salmonella SP12 mutants as antigen carriers |
| 08/30/2005 | US6936248 Methods of inhibiting GPR-9-6 function |
| 08/30/2005 | CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/30/2005 | CA1341488C Precursor antigens for human retorvirus (hiv-2) envelope glycoproteins, and immunologically related antigens |
| 08/25/2005 | WO2005078119A1 Probe for detecting nuclear receptor agonist or antagonist and method of screening agonist or antagonist to nuclear receptor with the use of the same |
| 08/25/2005 | US20050187378 nucleotide sequences encoding oligopeptide sequences which can render fusion partner proteins environmental stress resistant by binding thereto while conserving their intrinsic properties; recombinant vectors, and cells transformed by them |
| 08/25/2005 | US20050187159 Covalently bonding albumin to oligopeptide; biochemical conjugation; analyzing stability, therapy |
| 08/25/2005 | US20050186665 Expressed ligand - vascular intercellular signaling molecule |
| 08/25/2005 | US20050186664 Albumin fusion proteins |
| 08/25/2005 | US20050186621 Using host cells to propagate preferential viral proteins for use in generating vaccines aganist microorganismal infection |
| 08/25/2005 | US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/25/2005 | US20050186209 Protein between 30% but less than 100% identical to a human protein, contains a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 08/25/2005 | US20050186203 Isolated antibody bound to human insulin-like growth factor-I receptor, identification of its CDRs (complementarity-determining regions), inhibiting the tyrosine kinase activity of the IGF-IR receptor |
| 08/25/2005 | CA2849552A1 Hybrid polypeptides with selectable properties |
| 08/25/2005 | CA2601952A1 Probe for detecting nuclear receptor agonist or antagonist and method for screening agonist or antagonist to nuclear receptor using the same |
| 08/25/2005 | CA2555274A1 Chimeric vegf peptides |
| 08/25/2005 | CA2554089A1 Albumin fusion proteins |
| 08/25/2005 | CA2550401A1 Method and compositions for detecting botulinum neurotoxin |
| 08/24/2005 | EP1566441A1 Genes coding for hydroxynitrile lyase, recombinant proteins with hydroxynitrile lyase activity and their use |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1246919B1 Progenitor cell preservation factors and related methods and products |
| 08/24/2005 | CN1659284A Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 08/24/2005 | CN1659277A Novel phospholipases and uses thereof |
| 08/24/2005 | CN1659276A Phospholipases, nucleic acids encoding them and methods for making and using them |
| 08/24/2005 | CN1659180A Novel recombinant anticoagulant proteins |
| 08/24/2005 | CN1658901A Methods for treating TWEAK-related conditions |
| 08/23/2005 | US6933422 Nav2 channel gene-deficient mice |
| 08/23/2005 | US6933370 Methods for purifying highly anionic proteins |
| 08/23/2005 | US6933366 Specificity exchangers that redirect antibodies to bacterial adhesion receptors |
| 08/23/2005 | US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin |
| 08/23/2005 | US6933125 Human c-Maf compositions and methods of use thereof |
| 08/23/2005 | CA2193122C Tetracycline-regulated transcriptional modulators |
| 08/18/2005 | US20050182250 Nucleotide sequences coding fluorescent reporter protlein and scaffolds for use as diagnostic and imaging tool in genetic analysis |
| 08/18/2005 | US20050181506 Chromosome-based platforms |
| 08/18/2005 | US20050181501 Anti-TECK antibodies and methods of use therefor |
| 08/18/2005 | US20050181474 Transport peptides and uses therefor |
| 08/18/2005 | US20050181450 Novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein and an IP3 indicator |
| 08/18/2005 | US20050181422 Process for high throughput screening of CpG-based immuno-agonist/antagonist |
| 08/18/2005 | US20050181419 For detection of Mycobacterium tuberculosis infection |
| 08/18/2005 | US20050180996 Vaccine composition specific to glyceroaldehyde-3-phosphate dehydrogenase for use as tool in prevention and treatment of coccidiosis; veterinary medicine |
| 08/17/2005 | EP1563834A1 Hollow nanoparticles of protein and drug using the same |
| 08/17/2005 | EP1562967A2 Adipocyte complement related protein zacrp14 |
| 08/17/2005 | EP1562587A2 Novel compositions and methods for the treatment of immune related diseases |
| 08/17/2005 | EP0975674B1 Immunotoxins, comprising an onc protein, directed against malignant cells |